Corrigenda

Corrigendum: Measuring the Use of End-of-Life Symptom Relief Medications in Long-Term Care Homes—a Qualitative Study

Rhiannon L. Roberts, MScPH1, Christina Milani, MSc2, Colleen Webber, PhD1,2, Shirley H. Bush, MBBS, PgDip, Pall Med1,2,3, Kaitlyn Boese, MD1,3, Jessica E. Simon, MB, ChB4, James Downar, MD, MHSc1,2,3, Amit Arya, MD5,6, Peter Tanuseputro, MD, MHSc1,2,3, Sarina R. Isenberg, PhD, MA3,2,5,7
1Ottawa Hospital Research Institute, Ottawa, ON
2Bruyère Research Institute, Ottawa, ON
3Department of Medicine, Division of Palliative Care, University of Ottawa, Ottawa, ON
4Department of Oncology, Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB
5Department of Family and Community Medicine, University of Toronto, Toronto, ON
6Kensington Research Institute, Toronto, ON
7School of Epidemiology and Public Health, Faculty of Medicine, Ottawa, ON

DOI: https://doi.org/10.5770/cgj.27.765

Original Citation:

Roberts RL, Milani C, Webber C, Bush SH, Boese K, Simon JE, Downar J, Tanuseputro P, Isenber SR. Measuring the Use of End-of-Life Symptom Relief Medications in Long-Term Care Homes-a Qualitative Study. Canadian Geriatric Journal. 2024;27(1):29–46. https://doi.org/10.5770/cgj.27.712

Description of error: The original article did not include one funding source. The additional funding source is indicated by bold in the following:

Funding Statement: This study received funding from the College of Family Physicians of Canada COVID-19 Pandemic Response and Impact Grant Program. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. This project has been funded in part by a contribution from Health Canada, Health Care Policy and Strategies Program. The views expressed herein do not necessarily represent the views of Health Canada. PT is supported by PSI Graham Farquharson Knowledge Translation Fellowship. SHB receives an Academic Protected Time Award from the Department of Medicine, University of Ottawa, Ottawa, Canada. The funders had no influence in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.


(Return to Top)


COPYRIGHT

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No-Derivative license (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.


Canadian Geriatrics Journal, Vol. 27, No. 2, JUNE 2024